cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Eyepoint Pharmaceuticals Inc
9 own
18 watching
Current Price
$6.61
$0.36
(5.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
235.8M
52-Week High
52-Week High
15.63000
52-Week Low
52-Week Low
2.19000
Average Volume
Average Volume
1.18M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization235.8M
icon52-Week High15.63000
icon52-Week Low2.19000
iconAverage Volume1.18M
iconDividend Yield--
iconP/E Ratio--
What does the Eyepoint Pharmaceuticals Inc do?
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery. It is also developing EYP-1901, a twice-yearly bioerodible formulation of tyrosine kinase inhibitor for the treatment of wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion; and YUTIQ50 for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. It also has a commercial alliance with ImprimisRx PA, Inc. for the joint promotion of DEXYCU for the treatment of post-operative inflammation following ocular surgery. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.
Read More
How much money does Eyepoint Pharmaceuticals Inc make?
News & Events about Eyepoint Pharmaceuticals Inc.
PR Newswire
7 months ago
Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? PR Newswire NEW YORK, May 3, 2023 NEW YORK...
Globe Newswire
9 months ago
Phase 2 DAVIO 2 clinical trial in wet AMD on track with topline data anticipated by year-end 2023 Phase 2 PAVIA clinical trial in non-proliferative diabetic retinopathy (NPDR) on track with enrollment completion anticipated in 4Q 2023 Net product revenues for Full Year 2022 of $39.9 million, a 13.0...
Globe Newswire
9 months ago
WATERTOWN, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that EyePoint Pharmaceuticals will present at the ...
Globe Newswire
9 months ago
WATERTOWN, Mass. and NEW HAVEN, Conn., Feb. 27, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, and Rallybio Corporation, a clinical-stage ...
PR Newswire
10 months ago
EYEPOINT SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options EYEPOINT SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors...
Frequently Asked Questions
Frequently Asked Questions
What is Eyepoint Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Eyepoint Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Eyepoint Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Eyepoint Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Eyepoint Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Eyepoint Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Eyepoint Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Eyepoint Pharmaceuticals Inc?
plus_minus_icon
What percentage is Eyepoint Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Eyepoint Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.61
$0.36
(5.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00